These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33714283)

  • 1. Preformulation characterization and identification of excipients for nevirapine loaded niosomes.
    Witika BA; Walker RB
    Pharmazie; 2021 Feb; 76(2):77-83. PubMed ID: 33714283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, manufacture and characterization of niosomes for the delivery for nevirapine.
    Witika BA; Walker RB
    Pharmazie; 2019 Feb; 74(2):91-96. PubMed ID: 30782257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.
    Abdelkader H; Ismail S; Kamal A; Alany RG
    Pharmazie; 2010 Nov; 65(11):811-7. PubMed ID: 21155387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of formulation variables and excipient interaction on the production of niosomes.
    Sezgin-Bayindir Z; Yuksel N
    AAPS PharmSciTech; 2012 Sep; 13(3):826-35. PubMed ID: 22644706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyloxapol niosomes as prospective drug delivery module for antiretroviral drug nevirapine.
    Mehta SK; Jindal N
    AAPS PharmSciTech; 2015 Feb; 16(1):67-75. PubMed ID: 25182386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, Characterization and
    Patel P; Barot T; Kulkarni P
    Curr Drug Deliv; 2020; 17(3):257-268. PubMed ID: 32056523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
    Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
    Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
    Hasan AA
    Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of formulation compositions on niosomal preparations.
    Chaw CS; Kim KY
    Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and characterization of catechin-loaded proniosomes for food fortification.
    Shruthi PA; Pushpadass HA; Magdaline Eljeeva Emerald F; Surendra Nath B; Laxmana Naik N
    J Sci Food Agric; 2021 Apr; 101(6):2439-2448. PubMed ID: 33027542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
    Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
    Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin.
    Imran M; Shah MR; Ullah F; Ullah S; Elhissi AM; Nawaz W; Ahmad F; Sadiq A; Ali I
    Drug Deliv; 2016 Nov; 23(9):3653-3664. PubMed ID: 27886514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
    Bendas ER; Abdullah H; El-Komy MH; Kassem MA
    Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol.
    Devaraj GN; Parakh SR; Devraj R; Apte SS; Rao BR; Rambhau D
    J Colloid Interface Sci; 2002 Jul; 251(2):360-5. PubMed ID: 16290741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein.
    Khan MI; Madni A; Peltonen L
    Eur J Pharm Sci; 2016 Dec; 95():88-95. PubMed ID: 27600819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.
    Lin T; Fang Q; Peng D; Huang X; Zhu T; Luo Q; Zhou K; Chen W
    Drug Deliv; 2013; 20(7):277-84. PubMed ID: 24044645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium.
    Abd-Elbary A; El-laithy HM; Tadros MI
    Int J Pharm; 2008 Jun; 357(1-2):189-98. PubMed ID: 18339494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes.
    Junyaprasert VB; Teeranachaideekul V; Supaperm T
    AAPS PharmSciTech; 2008; 9(3):851-9. PubMed ID: 18636334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor.
    El-Sayed MM; Hussein AK; Sarhan HA; Mansour HF
    Drug Dev Ind Pharm; 2017 Jun; 43(6):902-910. PubMed ID: 27977311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement.
    Kamboj S; Saini V; Bala S
    ScientificWorldJournal; 2014; 2014():959741. PubMed ID: 24672401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.